 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/835325
European Orphan Diseases Market
|
Description: |
This research service deals with market drivers, restraints, market trends, competitive structure , revenues, technology trends and market attractiveness analysis of the European orphan diseases market.
Research Overview
This Frost & Sullivan research service titled European Orphan Diseases Market provides insight into industry challenges, market drivers and market restraints and includes strategic recommendations. Revenue forecasts are offered along with an in-depth examination of the market’s competitive structure and a brand analysis of current market offerings. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: orphan diseases, Gaucher’s Disease and Pulmonary Arterial Hypertension (PAH) markets in Europe.
This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.
Market Overview
Niche Blockbusters Offer Promising Growth Potential
The patent expiry of blockbuster molecules has resulted in large pharmaceutical companies confronting intense competition from generics. CEOs have had to rethink strategies and devise alternative approaches to maintain the growth of their organisation and satisfy stakeholders. A focus on the market for niche blockbuster drugs represents a potential strategy that can be pursued by large pharmaceutical companies. For instance, there has been strong growth in the orphan diseases market, due to various incentives and benefits provided by governments. In the European Union (EU), the emphasis is on orphan diseases, as it is a promising, emergent market that offers the prospect of assured return on investment (ROI).
As leading pharmaceutical companies are facing increasing competition because of impending patent expiries of blockbuster drugs, a number of companies are pursuing merger and acquisition of small biotechnology companies. "The market is set to witness major consolidation due to mergers and acquisitions among big pharmaceuticals and small biotech companies," notes the analyst of this research. "The lack of adequate investment to support the development of newer therapies and technologies has been a major challenge for small biotechnology companies, resulting in their tilt towards merging with larger companies."
The European orphan diseases market grapples with numerous challenges. Of these, the most serious are the lack of awareness, poor diagnosis and limited accessibility of orphan drugs. "There are diverse policies among EU member countries with regard to the accessibility of orphan drugs," remarks the analyst. "This is retarding market expansion."
EU-wide harmonisation in the context of accessibility processes and price policies will reduce delays in the availability of orphan drugs. EU-wide co-ordination will also help in streamlining the regulatory process governing these drugs. EU healthcare ministers should encourage frequent discussions with patients, patient support groups and industry representatives to ensure a transparent and rapid approval process for orphan drugs.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following markets in this research:
- Orphan diseases
- Gaucher’s disease
- Pulmonary arterial hypertension
- Frost & Sullivan Growth Partnership Services
Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results. |
|
Contents: |
Key Topics Covered:
EXECUTIVE SUMMARY
-Executive Summary of the European Orphan Diseases Market
--Overview of European Orphan Diseases Market
RESEARCH METHODOLOGY
-Objective and Scope
--Research Methodology
--Scope and Objective
MARKET OVERVIEW
-Market Overview
--Introduction
--Market Engineering Measurements
--Market Drivers
--Market Restraints
--Revenue Forecasts
INDUSTRY CHALLENGES
-Industry Challenges
--Major Industry Challenges
MARKET ENGINEERING RESEARCH FOR GAUCHER DISEASE MARKET
-Gaucher Disease Market
--Disease State Overview
--Market Engineering Measurements
--Market Drivers
--Market Restraints
--Revenue Forecasts
--Competitive Structure
--Brand Analysis
MARKET ENGINEERING RESEARCH FOR PULMONARY ARTERIAL HYPERTENSION MARKET
-Pulmonary Arterial Hypertension Market
--Disease State Overview
--Market Engineering Measurements
--Market Drivers
--Market Restraints
--Revenue Forecasts
--Competitive Structure
--Brand Analysis
STRATEGIC RECOMMENDATIONS
-Market Engineering Recommendations
--Strategic Recommendations
DATABASE OF KEY INDUSTRY PARTICIPANTS
-Key Industry Participants
--Major Participants
APPENDIX
-Decision Support Database Tables
--HIV Prevalence
--AIDS Incidence
--Hypertension Prevalence
--Coronary Heart Disease Prevalence
--Multiple Sclerosis Prevalence
List of Figures
- Impact of top five industry challenges in the European orphan diseases market from 2008 to 2015
- Different types of rare diseases related to the European orphan diseases market in 2008
- Comparison of policies related to the world orphan diseases market in 2008
- Accessibility of orphan drugs in EU-5 and Benelux in Europe in 2008
- Market drivers ranked in order of impact in the European orphan diseases market from 2008 to 2015
- Market restraints ranked in order of impact in the European orphan diseases market from 2008 to 2015
- Revenue forecasts for the European orphan diseases market from 2005 to 2015
- Market drivers ranked in order of impact in European Gaucher disease market from 2008 to 2015
- Market restraints ranked in order of impact in the European Gaucher disease market from 2008 to 2015
- Competitive structure of the European Gaucher disease market in 2008
- Available therapeutic drugs in the European Gaucher disease market in 2008
- Pipeline drugs in development in the European Gaucher disease market in 2008
- SWOT analysis of Cerezyme in the European Gaucher disease market in 2008
- SWOT Analysis of Zavesca in the European Gaucher disease market in 2008
- Revenue forecasts for the European Gaucher disease market from 2005 to 2015
- NYHA/WHO classification of functional status of patients in the European PAH market in 2008
- Market drivers ranked in order of impact in the European PAH market from 2008 to 2015
- Market restraints ranked in order of impact in the European PAH market from 2008 to 2015
- Competitive structure of the European PAH market in 2008
- Available therapeutic drugs in the European PAH market in 2008
- Pipeline drugs in development in the European PAH market in 2008
- SWOT analysis of Tracleer in the European PAH market in 2008
- SWOT Analysis of Remodulin in the European PAH market in 2008
- SWOT Analysis of Flolan in the European PAH market in 2008
- SWOT Analysis of Revatio in the European PAH market in 2008
- SWOT Analysis of Ventavis in the European PAH market in 2008
- Revenue forecasts for the European PAH market from 2005 to 2015 |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/835325
Order by Fax - using the order form below
Order By Post - print the order form below and send to
|
|
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2
Printed 13/02/2012 07:39:02 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
|
Product Name: |
European Orphan Diseases Market
|
|
Web Address: |
http://www.researchandmarkets.com/reports/835325
|
|
Office Code: |
|
OC8IHINLSNNSS
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Site License
|
|
€4,968.00
|
|
Electronic and Hard Copy (PDF)
- Site License
|
|
€5,350.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic (PDF)
- Enterprisewide
|
|
€6,114.00
|
|
Electronic and Hard Copy (PDF)
- Enterprisewide
|
|
€6,496.00 + EUR€ 50.00 Shipping/Handling *
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
|
|
|
First Name: |
Last Name: |
|
Email Address: |
|
|
Job Title: |
|
|
Organisation: |
|
|
Address: |
|
|
City: |
|
|
Postal/Zip Code: |
|
|
Country: |
|
|
Phone Number: |
|
|
Fax Number: |
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
Page 2 of 2
Printed 13/02/2012 07:39:02
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
|
American Express
|
|
|
Diners Club
|
|
|
Master Card
|
|
|
Visa
|
|
|
|
|
|
|
Cardholder's Name: |
|
|
|
|
Cardholder's Signature: |
|
|
|
|
Expiry Date: |
/ |
|
|
|
Card Number: |
|
|
|
|
CVV Security Code: |
|
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
|
|
|
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
|
|
|
|
Please transfer funds to:
|
|
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
|
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
|
|
|
|
